Epidermal Barrier Parameters in Psoriasis: Implications in Assessing Disease Severity
Journal of Personalized Medicine · 05.07.2024 · 14 (7) · 728
DOI: 10.3390/jpm14070728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 05.07.2024. Verfasst von Silviu-Horia Morariu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psoriasis is characterized by an aberrant immune response due to myeloid dendritic cells and T helper cells intertwining with keratinocyte hyperproliferation. Skin integrity alterations may predispose patients to physiological imbalances, such as xerosis, reduced elasticity, and increased friability. This study aims to assess the epidermal barrier dysfunction in chronic plaque psoriasis and gain a comprehensive view of the dynamic changes in the epidermal barrier during various topical therapies. Adult patients with chronic plaque psoriasis were enrolled in this observational study. For each patient, skin barrier parameters, stratum corneum hydration (SCH), transepidermal water loss (TEWL), elasticity, erythema, and melanin levels were measured in lesional and non-lesional skin. Two extensions of the initial study design, with subsequent epidermal barrier determinations, were made as follows: one in which patients with moderate psoriasis were treated with clobetasol propionate 0.5% and the second one in which mild psoriasis was treated with either clobetasol propionate 0.5% or clobetasol propionate 0.5% with 10% urea. TEWL and erythema were found to be higher in the sites affected by psoriatic lesions than the unaffected sites, while SCH and elasticity were decreased. Severe psoriasis presented with higher TEWL (p = 0.032), erythema (p = 0.002), and lower SCH (p < 0.001) compared with the mild and moderate forms. SCH significantly improved during clobetasol propionate 0.5% treatment (p = 0.015). Clobetasol propionate 0.5% with 10% urea was found to be superior to clobetasol propionate 0.5% in improving TEWL and SCH in psoriasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Pathophysiology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Iuliu Haţieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Dermatology Clinic, Mures Clinical County Hospital, 540342 Targu Mures, Romania.
- Endocrinology Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
- Department of Public Health, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.
Zitieren
APA
Morariu, S. H., Cotoi, O. S., Tiucă, O. M., Crișan, M., Garaga, L., Tiucă, R. A., Mariean, C. R., Buicu, F. C., & Nicolescu, A. C. (2024). Epidermal Barrier Parameters in Psoriasis: Implications in Assessing Disease Severity. Journal of Personalized Medicine, 14(7), 728. https://doi.org/10.3390/jpm14070728
Vancouver
Morariu SH, Cotoi OS, Tiucă OM, Crișan M, Garaga L, Tiucă RA, et al. Epidermal Barrier Parameters in Psoriasis: Implications in Assessing Disease Severity. Journal of Personalized Medicine. 2024;14(7):728. doi:10.3390/jpm14070728
BibTeX
@article{Morariu2024,
author = {Morariu, Silviu-Horia and Cotoi, Ovidiu Simion and Tiucă, Oana Mirela and Crișan, Maria and Garaga, Liuba and Tiucă, Robert Aurelian and Mariean, Claudia Raluca and Buicu, Florin Corneliu and Nicolescu, Alin Codrut},
title = {Epidermal Barrier Parameters in Psoriasis: Implications in Assessing Disease Severity},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {7},
pages = {728},
doi = {10.3390/jpm14070728}
}
EUVIMED